Related content

Effects of Pioglitazone Add-On to Gliclazide and Metformin on Glycemic Control in Patients with Type 2 Diabetes

By Al-Azzam Sayer I.   AlOmari Mousa   Khader Yousef S.   AlMahasneh Fatimah A.   Muflih Suhaib M.   Altawalbeh Shoroq  

Endocrine Research, Vol. 37, Iss. 1, 2012-02 ,pp. : 7-11

Informa Healthcare

Access to resources Recommend Favorite

Efficacy and tolerability of acarbose in Asian patients with type 2 diabetes inadequately controlled with diet and sulfonylureas

By Lin B.J.   Wu H.-P.   Huang H.S.   Huarng J.   Sison A.   bin Abdul Kadir D.K.   Cho C.-G.   Sridama W.   The Writing Group for the Asian Study of Acarbose with Sulfonylureas  

Journal of Diabetes and its Complications, Vol. 17, Iss. 4, 2003-07 ,pp. : 179-185

Elsevier

Access to resources Recommend Favorite

Rosiglitazone treatment increases nitric oxide production in human peripheral skin - A controlled clinical trial in patients with type 2 diabetes mellitus

By Vinik A.I.   Stansberry K.B.   Barlow P.M.  

Journal of Diabetes and its Complications, Vol. 17, Iss. 5, 2003-09 ,pp. : 279-285

Elsevier

Access to resources Recommend Favorite

Efficacy and safety over 26 weeks of an oral treatment strategy including sitagliptin compared with an injectable treatment strategy with liraglutide in patients with type 2 diabetes mellitus inadequately controlled on metformin: a randomised clinical trial

By Charbonnel B.   Steinberg H.   Eymard E.   Xu L.   Thakkar P.   Prabhu V.   Davies M.   Engel S.  

Diabetologia, Vol. 56, Iss. 7, 2013-07 ,pp. : 1503-1511

Springer Publishing Company

Access to resources Recommend Favorite

Spotlight on Rosiglitazone in the Management of Type 2 Diabetes Mellitus

By Wagstaff A.J.   Goa K.L.  

Treatments in Endocrinology, Vol. 1, Iss. 6, 2002-01 ,pp. : 411-414

Adis International

Access to resources Recommend Favorite